Moore MR - Search Results

1

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event.

Golubchik T, Brueggemann AB, Street T, Gertz RE Jr, Spencer CC, Ho T, Giannoulatou E, Link-Gelles R, Harding RM, Beall B, Peto TE, Moore MR, Donnelly P, Crook DW, Bowden R. Golubchik T, et al. Among authors: moore mr. Nat Genet. 2012 Jan 29;44(3):352-5. doi: 10.1038/ng.1072. Nat Genet. 2012. PMID: 22286217 Free PMC article.

2

Shifting genetic structure of invasive serotype 19A pneumococci in the United States.

Beall BW, Gertz RE, Hulkower RL, Whitney CG, Moore MR, Brueggemann AB. Beall BW, et al. Among authors: moore mr. J Infect Dis. 2011 May 15;203(10):1360-8. doi: 10.1093/infdis/jir052. Epub 2011 Mar 11. J Infect Dis. 2011. PMID: 21398395 Free PMC article.

3

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.

Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B; Active Bacterial Core Surveillance Team. Pai R, et al. Among authors: moore mr. J Infect Dis. 2005 Dec 1;192(11):1988-95. doi: 10.1086/498043. Epub 2005 Nov 1. J Infect Dis. 2005. PMID: 16267772

4

Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B. Moore MR, et al. J Infect Dis. 2008 Apr 1;197(7):1016-27. doi: 10.1086/528996. J Infect Dis. 2008. PMID: 18419539

5

Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020.

Link-Gelles R, Taylor T, Moore MR; Active Bacterial Core Surveillance Team. Link-Gelles R, et al. Among authors: moore mr. Vaccine. 2013 May 24;31(22):2572-7. doi: 10.1016/j.vaccine.2013.03.049. Epub 2013 Apr 11. Vaccine. 2013. PMID: 23583813

6

Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children.

Muhammad RD, Oza-Frank R, Zell E, Link-Gelles R, Narayan KM, Schaffner W, Thomas A, Lexau C, Bennett NM, Farley MM, Harrison LH, Reingold A, Hadler J, Beall B, Klugman KP, Moore MR. Muhammad RD, et al. Among authors: moore mr. Clin Infect Dis. 2013 Mar;56(5):e59-67. doi: 10.1093/cid/cis971. Epub 2012 Nov 15. Clin Infect Dis. 2013. PMID: 23155149

7

Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.

Cho BH, Stoecker C, Link-Gelles R, Moore MR. Cho BH, et al. Among authors: moore mr. Vaccine. 2013 Dec 5;31(50):6011-21. doi: 10.1016/j.vaccine.2013.10.024. Epub 2013 Oct 19. Vaccine. 2013. PMID: 24148572

8

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.

Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, Farley MM, Jorgensen JH, Lexau CA, Petit S, Reingold A, Schaffner W, Thomas A, Whitney CG, Harrison LH. Hsu HE, et al. Among authors: moore mr. N Engl J Med. 2009 Jan 15;360(3):244-56. doi: 10.1056/NEJMoa0800836. N Engl J Med. 2009. PMID: 19144940 Free PMC article.

9

Cost-effectiveness of using 2 vs 3 primary doses of 13-valent pneumococcal conjugate vaccine.

Stoecker C, Hampton LM, Link-Gelles R, Messonnier ML, Zhou F, Moore MR. Stoecker C, et al. Among authors: moore mr. Pediatrics. 2013 Aug;132(2):e324-32. doi: 10.1542/peds.2012-3350. Epub 2013 Jul 1. Pediatrics. 2013. PMID: 23821695

10

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.

Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, Petit S, Zansky SM, Harrison LH, Reingold A, Miller L, Scherzinger K, Thomas A, Farley MM, Zell ER, Taylor TH Jr, Pondo T, Rodgers L, McGee L, Beall B, Jorgensen JH, Whitney CG. Moore MR, et al. Lancet Infect Dis. 2015 Mar;15(3):301-9. doi: 10.1016/S1473-3099(14)71081-3. Epub 2015 Feb 3. Lancet Infect Dis. 2015. PMID: 25656600 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

553 results

Search Page

Filters